Literature DB >> 30814245

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.

Denis Querleu1, François Planchamp1, Luis Chiva2, Christina Fotopoulou3, Desmond Barton4, David Cibula5, Giovanni Aletti6, Silvestro Carinelli6, Carien Creutzberg7, Ben Davidson8, Philip Harter2,3, Lene Lundvall2,3, Christian Marth9, Philippe Morice10, Arash Rafii11, Isabelle Ray-Coquard12, Andrea Rockall3, Christiana Sessa13, Ate van der Zee14, Ignace Vergote15, Andreas duBois2,3.   

Abstract

METHODS: The European Society of Gynaecological Oncology council nominated an international multidisciplinary development group made of practicing clinicians who have demonstrated leadership and interest in the care of ovarian cancer (20 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Before publication, the guidelines were reviewed by 66 international reviewers independent from the development group including patients representatives.
RESULTS: The guidelines cover preoperative workup, specialized multidisciplinary decision making, and surgical management of diagnosed epithelial ovarian, fallopian tube, and peritoneal cancers. The guidelines are also illustrated by algorithms.
© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

Entities:  

Keywords:  Algorithms; Guidelines; Ovarian cancer; Surgery

Mesh:

Year:  2017        PMID: 30814245     DOI: 10.1097/IGC.0000000000001041

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  25 in total

1.  Diaphragmatic Peritonectomy and Full-Thickness Resection in CRS/HIPEC May Allow Higher Completeness of Cytoreduction Rates with a Low Rate of Respiratory Complications.

Authors:  Andrea Craus-Miguel; Juan José Segura-Sampedro; Xavier González-Argenté; Rafael Morales-Soriano
Journal:  Ann Surg Oncol       Date:  2021-01-06       Impact factor: 5.344

Review 2.  CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-Radiology In Training.

Authors:  Maria Clara Fernandes; Ines Nikolovski; Kara Long Roche; Yulia Lakhman
Journal:  Radiology       Date:  2022-05-24       Impact factor: 29.146

3.  Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Authors:  Min Li; Tianjiao Zhang; Jing Zhu; Yuebo Li; Wenying Chen; Yanhu Xie; Wei Zhang; Rongzhu Chen; Wei Wei; Guihong Wang; Jiwei Qin; Weidong Zhao; Dabao Wu; Zhen Shen; Björn Nashan; Ying Zhou
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

4.  Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.

Authors:  Leonardo Rundo; Lucian Beer; Lorena Escudero Sanchez; Mireia Crispin-Ortuzar; Marika Reinius; Cathal McCague; Hilal Sahin; Vlad Bura; Roxana Pintican; Marta Zerunian; Stephan Ursprung; Iris Allajbeu; Helen Addley; Paula Martin-Gonzalez; Thomas Buddenkotte; Naveena Singh; Anju Sahdev; Ionut-Gabriel Funingana; Mercedes Jimenez-Linan; Florian Markowetz; James D Brenton; Evis Sala; Ramona Woitek
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

Review 5.  IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers.

Authors:  Nadeem R Abu-Rustum; Roberto Angioli; Arthur E Bailey; Vance Broach; Alessandro Buda; Michelle R Coriddi; Joseph H Dayan; Michael Frumovitz; Yong Man Kim; Rainer Kimmig; Mario M Leitao; Mustafa Zelal Muallem; Matt McKittrick; Babak Mehrara; Roberto Montera; Lea A Moukarzel; Raj Naik; Silvana Pedra Nobre; Marie Plante; Francesco Plotti; Oliver Zivanovic
Journal:  Int J Gynecol Cancer       Date:  2020-03-30       Impact factor: 3.437

6.  Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.

Authors:  Vincent Q Sier; Joost R van der Vorst; Paul H A Quax; Margreet R de Vries; Elham Zonoobi; Alexander L Vahrmeijer; Ilona A Dekkers; Lioe-Fee de Geus-Oei; Anke M Smits; Weibo Cai; Cornelis F M Sier; Marie José T H Goumans; Lukas J A C Hawinkels
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

7.  Potential of osteopontin in the management of epithelial ovarian cancer.

Authors:  Katarina Cerne; Benjamin Hadzialjevic; Erik Skof; Ivan Verdenik; Borut Kobal
Journal:  Radiol Oncol       Date:  2019-01-31       Impact factor: 2.991

8.  Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers.

Authors:  Tung Tung Tsoi; Keith W H Chiu; M Y Chu; Hextan Y S Ngan; Elaine Y P Lee
Journal:  J Ovarian Res       Date:  2020-05-20       Impact factor: 4.234

Review 9.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

Review 10.  Ovarian cancer staging: What the surgeon needs to know.

Authors:  Lucas Roberto Lelis Botelho de Oliveira; Natally Horvat; Pamela Ines Causa Andrieu; Pedro Sergio Brito Panizza; Giovanni Guido Cerri; Publio Cesar Cavalcante Viana
Journal:  Br J Radiol       Date:  2021-07-21       Impact factor: 3.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.